Search research articles
Contact Us
Filters
Showing results (231-240 of 326) with videos related to
Page
of 33
Sort By:
Hemasphere
|
March 3, 2021
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
Irene Della Starza, Vittorio Nunes, Federica Lovisa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 12, 2020
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
Maria Caterina Rotiroti, Chiara Buracchi, Silvia Arcangeli, et al.
Journal of Hypertension
|
October 21, 2015
A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients
Fadl Elmula M Fadl Elmula, Paola Rebora, Anneli Talvik, et al.
JCI Insight
|
March 8, 2023
The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease
Erica Dander, Paola Vinci, Stefania Vetrano, et al.
Journal of Clinical Medicine
|
October 28, 2023
Identifying Trauma Patients in Need for Emergency Surgery in the Prehospital Setting: The Prehospital Prediction of In-Hospital Emergency Treatment (PROPHET) Study
Stefano Isgrò, Marco Giani, Laura Antolini, et al.
Blood
|
January 29, 2021
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants
Grazia Fazio, Michela Bardini, Paola De Lorenzo, et al.
Pediatric Blood & Cancer
|
November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group
Wanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood
|
August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
Marieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Leukemia
|
August 28, 2023
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease
Carolina Caserta, Silvia Nucera, Matteo Barcella, et al.
Orphanet Journal of Rare Diseases
|
February 10, 2018
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Rossella Parini, Paola De Lorenzo, Andrea Dardis, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 326) with videos related to
Sort By:
Page
of 33
Hemasphere
|
March 3, 2021
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
Irene Della Starza, Vittorio Nunes, Federica Lovisa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 12, 2020
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
Maria Caterina Rotiroti, Chiara Buracchi, Silvia Arcangeli, et al.
Journal of Hypertension
|
October 21, 2015
A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients
Fadl Elmula M Fadl Elmula, Paola Rebora, Anneli Talvik, et al.
JCI Insight
|
March 8, 2023
The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease
Erica Dander, Paola Vinci, Stefania Vetrano, et al.
Journal of Clinical Medicine
|
October 28, 2023
Identifying Trauma Patients in Need for Emergency Surgery in the Prehospital Setting: The Prehospital Prediction of In-Hospital Emergency Treatment (PROPHET) Study
Stefano Isgrò, Marco Giani, Laura Antolini, et al.
Blood
|
January 29, 2021
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants
Grazia Fazio, Michela Bardini, Paola De Lorenzo, et al.
Pediatric Blood & Cancer
|
November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group
Wanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.
Blood
|
August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
Marieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Leukemia
|
August 28, 2023
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease
Carolina Caserta, Silvia Nucera, Matteo Barcella, et al.
Orphanet Journal of Rare Diseases
|
February 10, 2018
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Rossella Parini, Paola De Lorenzo, Andrea Dardis, et al.
Page
of 33